Home / News / Happy Health Raises $75M Series A to Expand AI-Powered Home-Based Care

Happy Health Raises $75M Series A to Expand AI-Powered Home-Based Care

Overview

Happy Health raised $75 million in Series A funding to expand its AI-powered platform for continuous, home-based healthcare.

The company combines its FDA-cleared Happy Ring with physician-guided care, initially focusing on sleep and sleep apnea.

The funding was led by ARCH Venture Partners and OpenLoop.

The News

Happy Health has secured $75 million in Series A funding to accelerate the development of its AI-powered platform for continuous healthcare delivered at home. ARCH Venture Partners and OpenLoop led the round, which will support the company’s efforts to shift diagnosis and monitoring beyond traditional clinical settings.

The Austin-based company is initially focused on sleep, using its clinical-grade Happy Ring to continuously monitor physiological signals. The wearable received FDA clearance in October 2024 and was subsequently cleared in June 2025 for at-home sleep testing, becoming the first FDA-cleared smart ring for multi-night sleep testing and 24/7 biometric monitoring.

Through its Happy Sleep platform, the company combines wearable data with a clinical care team of board-certified sleep physicians. Happy Health says its technology can help diagnose sleep apnea in as few as three nights, providing patients with a more convenient alternative to traditional sleep testing.

Industry Perspective

Healthcare is increasingly moving toward decentralized and home-based models, with wearable technologies enabling continuous monitoring rather than episodic assessments. Sleep represents a particularly strong application for this approach, as physiological signals collected overnight can provide insights that may be difficult to capture during conventional clinical visits.

Strategic Impact

The new funding gives Happy Health additional resources to scale its home-based care model and expand the role of AI and continuous physiological monitoring in healthcare. By combining an FDA-cleared wearable with diagnostic capabilities and physician-led care, the company aims to create a more accessible pathway for identifying and managing sleep-related conditions outside traditional healthcare settings.

Source: PRnewswire

Tagged:

Leave a Reply

Your email address will not be published. Required fields are marked *